# Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

> **NCT00532337** · PHASE2 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 285 (actual)

## Conditions studied

- Osteoporosis
- Osteopenia

## Interventions

- **DRUG:** ONO-5334
- **DRUG:** ONO-5334
- **DRUG:** ONO-5334
- **DRUG:** ONO-5334
- **DRUG:** ONO-5334

## Key facts

- **NCT ID:** NCT00532337
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532337, "Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00532337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*